Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 7.14
-0.04 (-0.56%)
Jun 12, 2026, 3:29 PM IST
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 931.5 million as of June 12, 2026. Its market cap has decreased by -41.12% in one year.
Market Cap
931.50M
Enterprise Value
1.11B
Revenue
1.13B
Ranking
n/a
PE Ratio
22.31
Stock Price
7.14
Market Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 931.50M, an increase of 225.00%. That is a compound annual growth rate of 14.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 931.50M | -17.17% |
| Dec 31, 2025 | 1.12B | -46.84% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 14.14B |
| Sigachi Industries | 7.89B |
| Bafna Pharmaceuticals | 3.91B |
| Valiant Laboratories | 3.69B |
| Nectar Lifesciences | 2.25B |
| Brooks Laboratories | 1.96B |
| Alpa Laboratories | 1.47B |
| Balaxi Pharmaceuticals | 1.26B |